Pirarubicin in Advanced Non-Small Cell Lung Cancer

Autor:	L. Edler, P. Drings, W. E. Berdel, E. Salewski, U. Gatzemeier, M. Stahl, I.U. Günther
Rok vydání:	1990
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Pirarubicin Phases of clinical research Hematology medicine.disease respiratory tract diseases Internal medicine medicine Non small cell Lung cancer business medicine.drug
Zdroj:	Oncology Research and Treatment. 13:180-184
ISSN:	2296-5262 2296-5270
DOI:	10.1159/000216754
Popis:	Forty-seven patients with advanced non-small cell lung cancer (NSCLC) were treated in a multicentre phase II study with pirarubicin (THP), 4’-O-tetrahydropyranyl-doxorubicin using a dosage of 70mg/ m2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d73584cb1f7e8df4a5a5d21ce56ccc31 https://doi.org/10.1159/000216754 Zobrazit plný text záznamu